Introduction
Meribank has been conducting investigational new drug (IND) application and planning clinical trials of the therapeutics drugs for pulmonary diseases and neurological diseases including bronchopulmonary dysplasia (BPD), chronic obstructive pulmonary disease (COPD), ischemic stroke, and cerebral palsy (CP).
Features / strengths
Meribank independent develops mesenchymal stem cells isolation and purification technologies which have been patented in USA and Taiwan. Meribank also skills in stem cell–related techniques that have been protected by global patent strategies, including:
Stem cells analysis and characterization platform
Stem cells scaling up platform
Specification in detail
